Supernus Pharmaceuticals Inc (SUPN)

Operating profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	-4,273	30,061	20,400	49,333	46,124	17,888	52,015	74,782	86,029	122,929	146,465	157,900	173,698	171,516	155,105	152,155	148,571	147,610	145,356	138,478
Revenue (ttm)	US$ in thousands	605,106	619,414	641,163	674,751	673,056	651,277	618,187	585,808	560,079	545,016	551,524	536,576	506,717	465,383	418,476	402,257	392,755	408,243	409,099	403,942
Operating profit margin		-0.71%	4.85%	3.18%	7.31%	6.85%	2.75%	8.41%	12.77%	15.36%	22.56%	26.56%	29.43%	34.28%	36.85%	37.06%	37.83%	37.83%	36.16%	35.53%	34.28%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-4,273K ÷ $605,106K
= -0.71%

Supernus Pharmaceuticals Inc's operating profit margin has fluctuated over the past eight quarters, ranging from as low as 2.21% in Q4 2023 to a high of 11.29% in Q1 2022. The operating profit margin represents the percentage of revenue that remains as profit after deducting operating expenses. The downward trend in the operating profit margin from Q1 2022 to Q4 2023 may indicate challenges in managing expenses relative to revenue generation. Further analysis of the company's cost structure, revenue streams, and operational efficiency may be necessary to understand the factors contributing to this fluctuation.